Presentation is loading. Please wait.

Presentation is loading. Please wait.

Toric Artiflex J.L.GüellI.M.O. Instituto de Microcirugía Ocular de Barcelona Universidad Autónoma de Barcelona Universidad de Lugano ESCRS Vienna 2011.

Similar presentations


Presentation on theme: "Toric Artiflex J.L.GüellI.M.O. Instituto de Microcirugía Ocular de Barcelona Universidad Autónoma de Barcelona Universidad de Lugano ESCRS Vienna 2011."— Presentation transcript:

1 Toric Artiflex J.L.GüellI.M.O. Instituto de Microcirugía Ocular de Barcelona Universidad Autónoma de Barcelona Universidad de Lugano ESCRS Vienna 2011

2 3.5mm4.9mm 2.8mm 4.8mm main advantages of the Artisan-Artiflex concept: A C B D E

3 ARTIFLEX® Toric PIOL Clinical results of the European Multicenter Study February 2010

4 Lens specifications ARTIFLEX ® Toric Overall Ø8.5 mm Body Ø6.0 mm Optical zone Ø 5.5 mm Body materialPolysiloxane Haptic width3.0 mm Haptic material PMMA AdhesiveLoctite ® Power range (D) CylinderSphere -1.0 to -13.5 -1.5-1.0 to -13.0 -2.0-1.0 to -12.5 -2.5-1.0 to -12.0 -3.0-1.0 to -11.5 -3.5-1.0 to -11.0 -4.0-1.0 to -10.5 -4.5-1.0 to -10.0 -5.0-1.0 to -9.5 Cylinders available at 0° and 90°

5 Study design 125 eyes 7 investigators - Camille Budo- Michiel Luger - Antonio Marinho- Ben Christiaans - Burkhard Dick- Jose Güell - Rudy Nuijts 6 months follow-up Primary study objective: Study the performance of the ARTIFLEX toric PIOL and establish the mechanical properties of the lens in the anterior chamber.

6 Efficacy Pre-op BSCVA ≥ 1.0 : 67.5% 6 months post-op UCVA ≥ 1.0: 63.6% Pre-op BSCVA vs. post-op UCVA

7 Deviation from emmetropia  0.5 D: 93.2%  1.0 D: 100%

8 Intended vs. achieved refraction 6 months follow-up, n=104  0.5 D: 81.7%  1.0 D: 99.0%

9 Absolute cylinder reduction 6 months follow-up, n=104

10 Induced astigmatism – vector analysis

11 Stability Spherical equivalent over time Manifest subjective refraction

12 Efficacy and safety index 1m3m6m Efficacy index UCVA post / BCVA pre 0.991.021.03 1m3m6m Safety index BCVA post / BCVA pre 1.111.141.13

13 Complications 1d1w1m3m6m n120 119114 Glare1.7%6.7%14.2%5.0%9.6% Halos0.8%8.3%11.7%10.1%4.4% Pigment0.8%5.8%12.5%12.6%15.8% Non-pigment1.7%4.2%10.0%12.6%12.3% Synechia0% 1.7%2.5%4.4% Oval pupil0.8% 0%0.8%2.6% Raised IOP0%4.2%1.7%0% SSI0% 0.8%0% Other2.5%3.3%1.7%6.1%1.8%

14 IOP Pre-op vs. post-op IOP

15 Endothelial Cell Count Comparison and outliers ECC Pre-op vs. post-op

16 Contrast sensitivity Preoperative and 3 months postoperative CS

17 forme frustre KC, high myopic astigmatism

18 postkeratoplasty hyperopic astigmatism


Download ppt "Toric Artiflex J.L.GüellI.M.O. Instituto de Microcirugía Ocular de Barcelona Universidad Autónoma de Barcelona Universidad de Lugano ESCRS Vienna 2011."

Similar presentations


Ads by Google